Association between chronic exposure to arsenic and slow nerve conduction velocity among adolescents in Taiwan

Journal of Health, Population and Nutrition

Volumn 24, Issue 2, 2006, Pages 182-189

  Tseng, Hung Pin ^a,d   Wang, Yuan Hung ^b   Wu, Meei Maan ^b   The, Hee Wen ^b   Chiou, Hung Yi ^b   Chen, Chien Jen ^c  

^a LOTUNG POH AI HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d Ching Kuo Institute of Management of Health   (Taiwan)

Author keywords

Arsenic; Arsenic exposure; Cross sectional studies; Nerve conduction velocity; Sensory action potential; Taiwan

Indexed keywords

ARSENIC; WELL WATER;

ADOLESCENT; ARM; ARSENIC POISONING; ARTICLE; BODY HEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENVIRONMENTAL EXPOSURE; FEMALE; FLUID INTAKE; HIGH SCHOOL; HUMAN; LEG; LONG TERM EXPOSURE; MALE; MOTOR NERVE CONDUCTION; NERVE CONDUCTION; NERVE POTENTIAL; PERIPHERAL NEUROPATHY; SCHOOL CHILD; SENSORY NERVE CONDUCTION; SURAL NERVE; TAIWAN; WATER CONTAMINATION;

ADOLESCENT; ARSENIC; ARSENIC POISONING; CHILD; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; FEMALE; HEALTH SURVEYS; HUMANS; LOGISTIC MODELS; MALE; MEDIAN NERVE; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; POPULATION SURVEILLANCE; QUESTIONNAIRES; RISK FACTORS; SCIATIC NERVE; TAIWAN; ULNAR NERVE; WATER POLLUTION, CHEMICAL;

EID: 33846473077     PISSN: 16060997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Jarup L. Hazards of heavy metal contamination. Br Med Bull 2003;68:167-82.
2. Chiou HY, Hsueh YM, Liaw KF, Horng SF, Chiang MH, Pu YS et al. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res 1995;55:1296-300.
3. Mazumder DN, Das GJ, Santra A, Pal A, Ghose A, Sarkar S. Chronic arsenic toxicity in West Bengal - the worst calamity in the world. J Indian Med Assoc 1998;96:4-7.
4. Tseng WP. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect 1977;19:109-19.
5. Chen CJ, Hsueh YM, Lai MS, Shyu MP, Chen SY, Wu MM et al. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 1995;25:53-60.
6. Lai MS, Hsueh YM, Chen CJ, Shyu MP, Chen SY, Kuo TL et al. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol 1994;139:484-92.
7. Chen CJ, Chiou HY, Chiang MH, Lin LJ, Tai TY. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler Thromb Vasc Biol 1996;16:504-10.
8. Tseng CH, Chong CK, Tseng CP, Hsueh YM, Chiou HY, Tseng CC et al. Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicol Lett 2003;137:15-21.
9. Chiou HY, Huang WI, Su CL, Chang SF, Hsu YH, Chen CJ. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 1997;28:1717-23.
10. Tseng CH. An overview on peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Angiology 2002;53:529-37.
11. Stetson DS, Silverstein BA, Keyserling WM, Wolfe RA, Albers JW. Median sensory distal amplitude and latency: comparisons between nonexposed managerial/professional employees and industrial workers. Am J Ind Med 1993;24:175-89.
12. Partanen J, Niskanen L, Lehtinen J, Mervaala F, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333:89-94.
13. Tkac I, Bril V. Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy. Diabetes Care 1998;21:1749-52.
14. Chhuttani PN, Chawla LS, Sharma TD. Arsenical neuropathy. Neurology 1967;17:269-74.
15. Gherardi RK, Chariot P, Vanderstigel M, Malapert D, Verroust J, Astier A et al. Organic arsenic-induced Guillain-Barre-like syndrome due to melarsoprol: a clinical, electrophysiological, and pathological study. Muscle Nerve 1990;13:637-45.
16. Goebel HH, Schmidt PF, Bohl J, Tettenborn B, Kramer G, Gutmann L. Polyneuropathy due to acute arsenic intoxication: biopsy studies. J Neuropathol Exp Neurol 1990;49:137-49.
17. Blom S, Lagerkvist B, Linderholm H. Arsenic exposure to smelter workers. Clinical and neurophysiological studies. Scand J Work Environ Health 1985;11:265-9.
18. Tseng CH. Abnormal current perception thresholds measured by neurometer among residents in blackfoot disease-hyperendemic villages in Taiwan. Toxicol Lett 2003;146:27-36.
19. Hafeman DM, Ahsan H, Louis ED, Siddique AB, Slavkovich V, Cheng Z et al. Association between arsenic exposure and a measure of subclinical sensory neuropathy in Bangladesh. J Occup Environ Med 2005;47:778-84.
20. Rahman MM, Chowdhury UK, Mukherjee SC, Mondal BK, Paul K, Lodh D et al. Chronic arsenic toxicity in Bangladesh and West Bengal, India - a review and commentary. J Toxicol Clin Toxicol 2001;39:683-700.
21. Kreiss K, Zack MM, Landrigan PJ, Feldman RG, Niles CA, Chirico-Post J et al. Neurologic evaluation of a population exposed to arsenic in Alaskan well water. Arch Environ Health 1983;38:116-21.
22. Kawasaki S, Yazawa S, Ohnishi A, Ohi T. Chronic and predominantly sensory polyneuropathy in Toroku Valley where a mining company produced arsenic. Rinsho Shinkeigaku 2002;42:504-11.
23. Trojaborg WT, Moon A, Andersen BB, Trojaborg NS. Sural nerve conduction parameters in normal subjects related to age, gender, temperature, and height: a reappraisal. Muscle Nerve 1992;15:666-71.
24. Buschbacher RM. Body mass index effect on common nerve conduction study measurements. Muscle Nerve 1998;21:1398-404.
25. Halar EM, DeLisa JA, Soine TL. Nerve conduction studies in upper extremities: skin temperature corrections. Arch Phys Med Rehabil 1983;64:412-6.
26. Rodriguez VM, Jimenez-Capdeville ME, Giordano M. The effects of arsenic exposure on the nervous system. Toxicol Lett 2003;145:1-18.
27. Vahter M Mechanisms of arsenic biotransformation. Toxicology 2002;27:211-7.
28. Dopp E, Hartmann LM, von Recklinghausen U, Florea AM, Rabieh S, Zimmermann U et al. Forced uptake of trivalent and pentavalent methylated and inorganic arsenic and its cyto-/genotoxicity in fibroblasts and hepatoma cells. Toxicol Sc 2005;87:46-56.
29. Thomas DJ, Styblo M, Lin S. The cellular metabolism and systemic toxicity of arsenic. Toxicol Appl Pharmacol 2001;176:127-44.
30. Buchet JP, Lauwerys R, Roels H. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int Arch Occup Environ Health 1981;48:71-9.